177 related articles for article (PubMed ID: 15590626)
1. Bisphosphonates and estrogens inhibit osteocyte apoptosis via distinct molecular mechanisms downstream of extracellular signal-regulated kinase activation.
Plotkin LI; Aguirre JI; Kousteni S; Manolagas SC; Bellido T
J Biol Chem; 2005 Feb; 280(8):7317-25. PubMed ID: 15590626
[TBL] [Abstract][Full Text] [Related]
2. Novel actions of bisphosphonates in bone: preservation of osteoblast and osteocyte viability.
Bellido T; Plotkin LI
Bone; 2011 Jul; 49(1):50-5. PubMed ID: 20727997
[TBL] [Abstract][Full Text] [Related]
3. Dissociation of the pro-apoptotic effects of bisphosphonates on osteoclasts from their anti-apoptotic effects on osteoblasts/osteocytes with novel analogs.
Plotkin LI; Manolagas SC; Bellido T
Bone; 2006 Sep; 39(3):443-52. PubMed ID: 16627025
[TBL] [Abstract][Full Text] [Related]
4. A novel ligand-independent function of the estrogen receptor is essential for osteocyte and osteoblast mechanotransduction.
Aguirre JI; Plotkin LI; Gortazar AR; Millan MM; O'Brien CA; Manolagas SC; Bellido T
J Biol Chem; 2007 Aug; 282(35):25501-8. PubMed ID: 17609204
[TBL] [Abstract][Full Text] [Related]
5. Transient versus sustained phosphorylation and nuclear accumulation of ERKs underlie anti-versus pro-apoptotic effects of estrogens.
Chen JR; Plotkin LI; Aguirre JI; Han L; Jilka RL; Kousteni S; Bellido T; Manolagas SC
J Biol Chem; 2005 Feb; 280(6):4632-8. PubMed ID: 15557324
[TBL] [Abstract][Full Text] [Related]
6. A bisphosphonate that does not affect osteoclasts prevents osteoblast and osteocyte apoptosis and the loss of bone strength induced by glucocorticoids in mice.
Plotkin LI; Bivi N; Bellido T
Bone; 2011 Jul; 49(1):122-7. PubMed ID: 20736091
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonate-induced, hemichannel-mediated, anti-apoptosis through the Src/ERK pathway: a gap junction-independent action of connexin43.
Plotkin LI; Bellido T
Cell Commun Adhes; 2001; 8(4-6):377-82. PubMed ID: 12064622
[TBL] [Abstract][Full Text] [Related]
8. Recruitment of the extracellular signal-regulated kinase/ribosomal S6 kinase signaling pathway to the NFATc4 transcription activation complex.
Yang TT; Xiong Q; Graef IA; Crabtree GR; Chow CW
Mol Cell Biol; 2005 Feb; 25(3):907-20. PubMed ID: 15657420
[TBL] [Abstract][Full Text] [Related]
9. Role of connexin 43 in the mechanism of action of alendronate: dissociation of anti-apoptotic and proliferative signaling pathways.
Lezcano V; Bellido T; Plotkin LI; Boland R; Morelli S
Arch Biochem Biophys; 2012 Feb; 518(2):95-102. PubMed ID: 22230328
[TBL] [Abstract][Full Text] [Related]
10. Connexin 43 is required for the anti-apoptotic effect of bisphosphonates on osteocytes and osteoblasts in vivo.
Plotkin LI; Lezcano V; Thostenson J; Weinstein RS; Manolagas SC; Bellido T
J Bone Miner Res; 2008 Nov; 23(11):1712-21. PubMed ID: 18597631
[TBL] [Abstract][Full Text] [Related]
11. Mechanical stimulation prevents osteocyte apoptosis: requirement of integrins, Src kinases, and ERKs.
Plotkin LI; Mathov I; Aguirre JI; Parfitt AM; Manolagas SC; Bellido T
Am J Physiol Cell Physiol; 2005 Sep; 289(3):C633-43. PubMed ID: 15872009
[TBL] [Abstract][Full Text] [Related]
12. EGF receptor and PKCδ kinase activate DNA damage-induced pro-survival and pro-apoptotic signaling via biphasic activation of ERK and MSK1 kinases.
Ohm AM; Affandi T; Reyland ME
J Biol Chem; 2019 Mar; 294(12):4488-4497. PubMed ID: 30679314
[TBL] [Abstract][Full Text] [Related]
13. Elevated ERK/p90 ribosomal S6 kinase activity underlies audiogenic seizure susceptibility in fragile X mice.
Sawicka K; Pyronneau A; Chao M; Bennett MV; Zukin RS
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6290-E6297. PubMed ID: 27663742
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk between caveolin-1/extracellular signal-regulated kinase (ERK) and β-catenin survival pathways in osteocyte mechanotransduction.
Gortazar AR; Martin-Millan M; Bravo B; Plotkin LI; Bellido T
J Biol Chem; 2013 Mar; 288(12):8168-8175. PubMed ID: 23362257
[TBL] [Abstract][Full Text] [Related]
15. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin.
Plotkin LI; Weinstein RS; Parfitt AM; Roberson PK; Manolagas SC; Bellido T
J Clin Invest; 1999 Nov; 104(10):1363-74. PubMed ID: 10562298
[TBL] [Abstract][Full Text] [Related]
16. Effects of estrogen deficiency and bisphosphonate therapy on osteocyte viability and microdamage accumulation in an ovine model of osteoporosis.
Brennan O; Kennedy OD; Lee TC; Rackard SM; O'Brien FJ
J Orthop Res; 2011 Mar; 29(3):419-24. PubMed ID: 20886644
[TBL] [Abstract][Full Text] [Related]
17. Thrombin-induced CCAAT/enhancer-binding protein β activation and IL-8/CXCL8 expression via MEKK1, ERK, and p90 ribosomal S6 kinase 1 in lung epithelial cells.
Lin CH; Nai PL; Bien MY; Yu CC; Chen BC
J Immunol; 2014 Jan; 192(1):338-48. PubMed ID: 24277696
[TBL] [Abstract][Full Text] [Related]
18. Targeting of magnolin on ERKs inhibits Ras/ERKs/RSK2-signaling-mediated neoplastic cell transformation.
Lee CJ; Lee HS; Ryu HW; Lee MH; Lee JY; Li Y; Dong Z; Lee HK; Oh SR; Cho YY
Carcinogenesis; 2014 Feb; 35(2):432-41. PubMed ID: 24031026
[TBL] [Abstract][Full Text] [Related]
19. N-methyl-D-aspartate and brain-derived neurotrophic factor induce distinct profiles of extracellular signal-regulated kinase, mitogen- and stress-activated kinase, and ribosomal s6 kinase phosphorylation in cortical neurons.
Rakhit S; Clark CJ; O'shaughnessy CT; Morris BJ
Mol Pharmacol; 2005 Apr; 67(4):1158-65. PubMed ID: 15625280
[TBL] [Abstract][Full Text] [Related]
20. ERK and RSK regulate distinct steps of a cellular program that induces transition from multicellular epithelium to single cell phenotype.
Čáslavský J; Klímová Z; Vomastek T
Cell Signal; 2013 Dec; 25(12):2743-51. PubMed ID: 24012955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
